These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6290229)

  • 1. Elevated liver enzymes in serum during suloctidil treatment.
    Schouten JA; Westerman RF
    Eur J Clin Pharmacol; 1982; 22(6):559-60. PubMed ID: 6290229
    [No Abstract]   [Full Text] [Related]  

  • 2. Suloctidil hepatitis: a case presentation.
    Kelly CP; England RE; McDonald GS; Weir DG
    Ir J Med Sci; 1987 Oct; 156(10):290-1. PubMed ID: 2828270
    [No Abstract]   [Full Text] [Related]  

  • 3. Suloctidil-induced hepatotoxicity.
    Chung MW; Komorowski RA; Varma RR
    Gastroenterology; 1988 Aug; 95(2):490-1. PubMed ID: 2839389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hepatitis caused by suloctidil].
    Lecocq E; Gay F; Van Geel P; Quirini M; Van Kerkem C
    Rev Med Brux; 1985 Oct; 6(8):573-4. PubMed ID: 3001893
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hepatitis caused by suloctidil with antinuclear antibodies].
    Brucker P; Ethève M; Filipetto MP; Biedermann J; Ferry M
    Gastroenterol Clin Biol; 1985 Nov; 9(11):851-3. PubMed ID: 3002894
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hepatitis induced by suloctidil].
    Beaujard E; Bon H; Gaillord F; Perrin D
    Presse Med; 1984 May; 13(19):1217-8. PubMed ID: 6326086
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hepatitis from suloctidil (Fluvisco)].
    Danan G; Pessayre D; Corbic M; Degott C; Benhamou JP
    Gastroenterol Clin Biol; 1984 Nov; 8(11):883-5. PubMed ID: 6098509
    [No Abstract]   [Full Text] [Related]  

  • 8. [Fulminating hepatitis due to suloctidil].
    Verneau A; Touchard G; Silvain C; Beauchant M
    Gastroenterol Clin Biol; 1985 Mar; 9(3):274-5. PubMed ID: 2989067
    [No Abstract]   [Full Text] [Related]  

  • 9. [Another cirrhogenic hepatitis from suloctidil (Fluvisco)].
    Trinchet JC; Beaugrand M; Callard P; Ferrier JP
    Gastroenterol Clin Biol; 1984; 8(6-7):578-9. PubMed ID: 6086437
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cirrhogenous hepatitis due to suloctidil (Fluvisco)].
    Perrin D; Beaujard E; Gaillard F
    Gastroenterol Clin Biol; 1983 Dec; 7(12):1042-4. PubMed ID: 6319217
    [No Abstract]   [Full Text] [Related]  

  • 11. [Suloctidil hepatitis: bringing into focus].
    Capron MH; Cabrières F; Lauga J
    Presse Med; 1984 Oct; 13(35):2155. PubMed ID: 6093092
    [No Abstract]   [Full Text] [Related]  

  • 12. Suloctidil: long-term trial in the aged. Study of microcirculation, viscosity, red cell deformability, fibrinolysis and lipid fractions.
    Merchan R; Zurita IE; Martinez JF
    Arzneimittelforschung; 1985; 35(5):855-7. PubMed ID: 2992530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical trial of suloctidil (sulocton) for the treatment of migraine (preliminary report)].
    Prusiński A
    Neurol Neurochir Pol; 1981; 15(3):309-11. PubMed ID: 6273762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A secondary prevention, randomized trial of suloctidil in patients with a recent history of thromboembolic stroke.
    Gent M; Blakely JA; Hachinski V; Roberts RS; Barnett HJ; Bayer NH; Carruthers SG; Collins SM; Gawel MG; Giroux-Klimek M
    Stroke; 1985; 16(3):416-24. PubMed ID: 2988158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Further observations on the use of Suloctidil (Sulocton) in the treatment of migraine].
    Prusiński A; Durko A; Głuszcz-Zielińska A; Szymańska R
    Wiad Lek; 1984 Dec; 37(23):1857-9. PubMed ID: 6099634
    [No Abstract]   [Full Text] [Related]  

  • 16. Suloctidil therapy in migraine: an open pilot study.
    Prusiński A; Durko A; Głuszcz-Zielińska A; Szymańska R
    Curr Med Res Opin; 1983; 8(9):631-3. PubMed ID: 6321107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Medium term treatment with suloctidil in obliterating arteriopathies of the lower limbs. Personal experience].
    Marongiu G; Dettori G; Gadeddu A; Noya G; Angius P; Biglioli P
    Minerva Cardioangiol; 1983; 31(7-8):407-10. PubMed ID: 6316206
    [No Abstract]   [Full Text] [Related]  

  • 18. Intermittent claudication: Suloctidil v.s. placebo treatment.
    Holm J; Lindblad L; Scherstén T; Suurkula M
    Vasa; 1984; 13(2):175-8. PubMed ID: 6331019
    [No Abstract]   [Full Text] [Related]  

  • 19. [Suloctidil (sulocton) in the treatment of atherosclerotic neurasthenic syndromes].
    Prusiński A; Kotwica S; Niewodniczy A; Split W
    Wiad Lek; 1982 May; 35(3-4):201-5. PubMed ID: 6287740
    [No Abstract]   [Full Text] [Related]  

  • 20. A double-blind trial of suloctidil v. placebo in intermittent claudication.
    Jones NA; De Haas H; Zahavi J; Kakkar VV
    Br J Surg; 1982 Jan; 69(1):38-40. PubMed ID: 6274471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.